Kids' heart test drug under study
NCT ID NCT04604782
First seen May 13, 2026 · Last updated Jun 23, 2026 · Updated 6 times
Summary
This study tests the safety and correct dose of a drug called regadenoson in children who need a heart stress test. The drug helps doctors see how well the heart is getting blood during a special MRI scan. Researchers will enroll 54 children of different ages to monitor side effects and how the drug works in their bodies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bambino Gesu Children Hospital
RECRUITINGRoma, 00165, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Bristol Royal Hospital for Children
NOT_YET_RECRUITINGBristol, BS28BJ, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
King's College London, Rayne Institute
RECRUITINGLondon, SE1 7EH, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Mitera Hospital
COMPLETEDAthens, 15123, Greece
-
Paris Public Hospitals System; Necker Hospital for Sick Children
TERMINATEDParis, 75015, France
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Regadenoson (Rapiscan)
What this could lead to
If successful, this could help doctors safely use regadenoson for heart stress tests in children, improving diagnosis of heart conditions.
What could go wrong
This is an early-phase study with only 54 participants, so results may not apply to all children. Side effects like low blood pressure or abnormal heart rhythms are possible.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.